Capricor Therapeutics
CAPR
#5589
Rank
A$1.83 B
Marketcap
A$33.75
Share price
-2.35%
Change (1 day)
51.82%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: A$1.83 Billion

As of February 2026 Capricor Therapeutics has a market cap of A$1.83 Billion. This makes Capricor Therapeutics the world's 5589th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.83 B-21.68%
2025A$2.34 B131.77%
2024A$1.01 B357.58%
2023A$0.22 B54.37%
2022A$0.14 B46.48%
2021A$97.74 M6.49%
2020A$91.78 M860.47%
2019A$9.55 M-47.68%
2018A$18.26 M-64.89%
2017A$52.03 M-34.11%
2016A$78.96 M15.14%
2015A$68.58 M27.85%
2014A$53.64 M25.97%
2013A$42.58 M2010.25%
2012A$2.01 M-90.44%
2011A$21.1 M-0.15%
2010A$21.13 M-42.06%
2009A$36.48 M25.4%
2008A$29.09 M-80.81%
2007A$0.15 B3857.36%
2006A$3.83 M-42.88%
2005A$6.7 M5.76%
2004A$6.34 M22.42%
2003A$5.18 M-72.39%
2002A$18.76 M

End of Day market cap according to different sources

On Feb 10th, 2026 the market cap of Capricor Therapeutics was reported to be:

A$1.78 Billion
by Nasdaq info icon info icon
A$1.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$811.39 B 44,097.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$19.02 B 936.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A$11.03 B 501.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.24 B 22.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$40.35 M-97.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$3.41 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA